期刊文献+

肺表面活性物质在新生儿转运中稳定呼吸道作用的临床探讨 被引量:2

Pulmonary surfactant as a valuable therapy for airway maintenance during neonatal transportation
下载PDF
导出
摘要 目的:探讨转运前在基层医院使用肺表面活性物质(PS)对转运过程中气道的稳定作用。方法:34例高危早产儿(实验组)转运前气管内滴注PS,与34例须转运但未使用PS的早产儿(对照组)进行前瞻性临床对照研究。结果:实验组与对照组比较,途中出现血氧饱和度下降的例数显著降低,氧分压、血氧饱和度、动脉/肺泡血氧分压比值显著增加;氧疗时间、机械通气时间和住院天数显著减少(P<0.05)。结论:转运前在基层医院使用PS,可稳定早产儿气道,保证转运质量,改善早产儿临床症状,缩短氧疗时间、机械通气时间和住院天数。 Objective:To investigate the efficacy of pulmonary surfactant (PS) replacement therapy for airway maintenance during neonatal transportation.Methods:A prospectively study was made for 34 premature infants administered with PS before transportation (experimental group) and 34 premature infants without PS administration before transportation (control group).Results:Compared with control group, the experimental group had a significantly lower desaturation during transportation, significantly decreased mechanical ventilation duration, supplemental oxygen therapy duration and hospitalized period.Conclusion:It is a valuable method to have PS replacement therapy for airway maintenance during neonatal transportation,which can level off neonate’s airway,guarantee transportation quality,improve their clinical symptoms,shorten time for oxygen therapy and mechanical ventilation and duration.
出处 《中国妇幼保健》 CAS 北大核心 2005年第12期1489-1491,共3页 Maternal and Child Health Care of China
基金 广东省医学科学研究基金(项目编号:A1999084) 广东省科技攻关项目(项目编号:2003C34217)
关键词 早产儿 呼吸窘迫综合征 肺表面活性物质 新生儿转运 Premature infants Respiratory distress syndrome Pulmonary surfactant Neonatal transportation
  • 相关文献

参考文献7

二级参考文献14

  • 1刘海荣,中国儿童状况分析报告,1994年,18页
  • 2许植之,新生儿呼吸系统疾病学,1993年,235页
  • 3金汉珍,实用新生儿学(第2版),1997年,350页
  • 4Enhorning G, Shennan A, Possmayer F, et al. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial [J]. Pediatrics, 1985, 76(2): 145-153.
  • 5Egberts J, de Winter JP, Sedin G, et al. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks'gestation: A randomized trial [J]. Pediatrics, 1993, 92(6): 768-774.
  • 6Hoekstra RE, Jackson JC, Myers TF, et al. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome [J]. Pediatrics, 1991, 88(1): 10-18.
  • 7Kattwinkel J, Bloom BT, Delmore p, et al. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 though 32 weeks' gestation [J]. Pediatrics, 1993, 92(1): 90-98.
  • 8Galan HL, Cipriani C, Coalson JJ, et al. Hyaline membrane disease surfactant prophylaxis in the preterm baboon: a comparison of postpartum versus in utero therapy [J]. Prenatal and Neonatal Medicine, 1996, 1(2): 122-130.
  • 9Kendig JW, Notter RH, Cox C, et al. A comparison of surfactant replacement as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation [J]. N Engl J Med, 1991, 324(13): 865-871.
  • 10Dunn MS, Shennan AT, Zayack D, et al. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment [J]. Pediatrics, 1991, 87(3): 377-386.

共引文献138

同被引文献13

引证文献2

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部